INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 31 July 2010
|
Total Net Assets |
£96.3m |
|
NAV per share |
159.6p |
|
Share Price |
136.8p |
|
Total value of unquoted investments |
£22.7m |
|
Total number of portfolio companies |
60 |
|
Cash |
4% |
|
Cash committed and reserved to unquoted investments |
12% |
|
Portfolio companies with < 1 year of cash |
8% |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
6.00 |
|
Micromet |
5.66 |
|
Amgen |
5.63 |
|
Genzyme |
5.35 |
|
Shire |
5.15 |
|
Alexion Pharmaceuticals |
4.13 |
|
Gilead Sciences |
3.30 |
|
EUSA Pharma |
3.11 |
|
Oxagen |
3.02 |
|
Insulet Corp |
2.82 |
|
|
----------- |
|
Total |
42.52 |
|
Geographical Allocation |
% |
|
United States |
75 |
|
Europe |
19 |
|
Cash |
4 |
|
Australia |
2 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
73 |
|
Unquoted |
23 |
|
Cash |
4 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
18 AUGUST 2010